Charles Milrod Source Confirmed

OverviewAI-generated summary

Dr. Charles Milrod is actively engaged in lymphoma research, with a focus on diagnosis, treatment, and viral-associated cancers and disorders. His work encompasses CAR-T cell therapy and chronic lymphocytic leukemia, as well as complications such as chemotherapy-related skin toxicity. Recent investigations include a multi-center phase 2 study on mosunetuzumab as a first-line therapy for lymphoma and a systematic review and meta-analysis of progression-free survival in follicular lymphoma. Other work has examined the use of immune checkpoint inhibitors in Hodgkin lymphoma and disparities in clinical trial representation.

Metrics

• h-index: 5
• Publications: 34
• Citations: 78